dc.contributor.author | Haddad J.J. |
dc.contributor.editor | |
dc.date | 2004 |
dc.date.accessioned | 2017-10-03T15:43:30Z |
dc.date.available | 2017-10-03T15:43:30Z |
dc.date.issued | 2004 |
dc.identifier | 10.1016/j.bbrc.2004.08.119 |
dc.identifier.isbn | |
dc.identifier.issn | |
dc.identifier.uri | http://hdl.handle.net/10938/12471 |
dc.description.abstract | The role of alcohol consumption and alcoholism as an addiction in regulating the chemistry of the brain and its physiology has gained a backlog of interest over the past few decades. Besides the notion that alcohol acts as a brain depressant, the molecular mechanisms and neuronal interactions are not well understood. Emerging evidence implicates alcohol as a neurochemical messenger that influences a cross talk amongst the nervous, immune, and endocrine systems. Specifically, alcohol acts as a crucial regulator of the hypothalamic-pituitary-adrenal (HPA) axis, thereby modulating the release of hormones, particularly adrenocorticotropic hormone (ACTH) and corticosterone (CORT). It is the aim of this review, therefore, to investigate current concepts on how alcohol, particularly ethanol, and alcoholism affect neuro-immune-endocrine neurochemical interactions via the regulation of the HPA axis, taking into consideration bio-behavioral and physiochemical aspects. © 2004 Published by Elsevier Inc. |
dc.format.extent | |
dc.format.extent | Pages: (361-371) |
dc.language | English |
dc.publisher | SAN DIEGO |
dc.relation.ispartof | Publication Name: Biochemical and Biophysical Research Communications; Publication Year: 2004; Volume: 323; no. 2; Pages: (361-371); |
dc.relation.ispartofseries | |
dc.relation.uri | |
dc.source | Scopus |
dc.subject.other | |
dc.title | Alcoholism and neuro-immune-endocrine interactions: Physiochemical aspects |
dc.type | Review |
dc.contributor.affiliation | Haddad, J.J., Department of Biology, Faculty of Arts and Sciences, Amer. Univ. Beirut, Beirut, Lebanon, United States |
dc.contributor.authorAddress | Department of Biology, Faculty of Arts and Sciences, Amer. Univ. Beirut, Beirut, LebanonUnited States; email: johnjhaddad@yahoo.co.uk |
dc.contributor.authorCorporate | University: American University of Beirut; Faculty: Faculty of Arts and Sciences; Department: Biology; |
dc.contributor.authorDepartment | Biology |
dc.contributor.authorDivision | |
dc.contributor.authorEmail | johnjhaddad@yahoo.co.uk |
dc.contributor.faculty | Faculty of Arts and Sciences |
dc.contributor.authorInitials | Haddad, JJ |
dc.contributor.authorOrcidID | |
dc.contributor.authorReprintAddress | Haddad, JJ (reprint author), Amer Univ Beirut, Fac Arts and Sci, Dept Biol, Beirut, Lebanon. |
dc.contributor.authorResearcherID | |
dc.contributor.authorUniversity | American University of Beirut |
dc.description.cited | ABOUSALEH MT, 1984, ACTA PSYCHIAT SCAND, V69, P112, DOI 10.1111-j.1600-0447.1984.tb02473.x; ADINOFF B, 1990, ARCH GEN PSYCHIAT, V47, P325; ADINOFF B, 1988, MED TOXICOL ADV DRUG, V3, P172; BAILLY D, 1989, HORM RES, V31, P72, DOI 10.1159-000181090; Beresford T, 1999, J STUD ALCOHOL, V60, P586; Brady KT, 1999, ALCOHOL RES HEALTH, V23, P263; BUYDENSBRANCHEY L, 1992, PSYCHONEUROENDOCRINO, V17, P45, DOI 10.1016-0306-4530(92)90075-I; Czarnecki Tomasz, 2003, Psychiatr Pol, V37, P503; Dai X, 2002, NEUROPSYCHOPHARMACOL, V27, P442, DOI 10.1016-S0893-133X(02)00308-1; de La Fuente J R, 1983, Alcohol Clin Exp Res, V7, P35; Devaud LL, 2000, NEUROCHEM INT, V37, P433, DOI 10.1016-S0197-0186(00)00052-8; EHLERS CL, 1987, REGUL PEPTIDES, V19, P345, DOI 10.1016-0167-0115(87)90176-5; Ehlert U, 2001, BIOL PSYCHOL, V57, P141, DOI 10.1016-S0301-0511(01)00092-8; Eşel Ertuğrul, 2003, Turk Psikiyatri Derg, V14, P60; Eskay RL, 1995, ANN NY ACAD SCI, V771, P105, DOI 10.1111-j.1749-6632.1995.tb44674.x; GEORGE SR, 1990, ALCOHOL CLIN EXP RES, V14, P425, DOI 10.1111-j.1530-0277.1990.tb00499.x; Gianoulakis C, 2004, CURR TOP MED CHEM, V4, P39, DOI 10.2174-1568026043451573; Gianoulakis C, 2003, ALCOHOL CLIN EXP RES, V27, P410, DOI 10.1097-01.ALC.0000056614.96137.B8; Haddad JJ, 2002, J NEUROIMMUNOL, V133, P1, DOI 10.1016-S0165-5728(02)00357-0; HALBREICH U, 1989, ALCOHOL CLIN EXP RES, V21, P834; Hernandez-Avila CA, 2002, BIOL PSYCHIAT, V51, P652, DOI 10.1016-S0006-3223(01)01334-8; Hoffman PL, 2003, INT REV NEUROBIOL, V56, P35, DOI 10.1016-S0074-7742(03)56002-0; Hundt W, 2001, ALCOHOL CLIN EXP RES, V25, P687, DOI 10.1111-j.1530-0277.2001.tb02268.x; IDA Y, 1992, DRUG ALCOHOL DEPEN, V31, P57, DOI 10.1016-0376-8716(92)90009-2; INDER WJ, 1995, CLIN ENDOCRINOL, V43, P283, DOI 10.1111-j.1365-2265.1995.tb02033.x; JANOWSKY DS, 1983, PSYCHIAT CLIN N AM, V6, P403; KEMPER A, 1990, DRUG ALCOHOL DEPEN, V25, P319, DOI 10.1016-0376-8716(90)90158-B; Kiefer F, 2001, BIOL PSYCHIAT, V49, P782, DOI 10.1016-S0006-3223(01)01081-2; Kiefer F, 2002, PSYCHOPHARMACOLOGY, V164, P239, DOI 10.1007-s00213-002-1255-3; Kim CK, 1999, ALCOHOL CLIN EXP RES, V23, P52; King AC, 2002, NEUROPSYCHOPHARMACOL, V26, P778, DOI 10.1016-S0893-133X(01)00416-X; Kinoshita H, 2001, ALCOHOL ALCOHOLISM, V36, P59, DOI 10.1093-alcalc-36.1.59; KNUDSEN GM, 1987, ALCOHOL CLIN EXP RES, V11, P323, DOI 10.1111-j.1530-0277.1987.tb01318.x; KNYCH ET, 1982, LIFE SCI, V31, P527, DOI 10.1016-0024-3205(82)90480-5; Lamblin F, 1996, ALCOHOL ALCOHOLISM, V31, P175; LEE S, 1994, ALCOHOL CLIN EXP RES, V18, P1242, DOI 10.1111-j.1530-0277.1994.tb00112.x; LEE S, 1994, MOL CELL NEUROSCI, V5, P442, DOI 10.1006-mcne.1994.1054; Lee S, 1997, J NEUROSCI, V17, P8856; Lee S, 2001, ALCOHOL CLIN EXP RES, V25, P98, DOI 10.1111-j.1530-0277.2001.tb02132.x; Lee S, 2003, ALCOHOL CLIN EXP RES, V27, P962, DOI 10.1097-01.ALC.0000076120.67014.ED; LEE S, 1993, ALCOHOL CLIN EXP RES, V17, P940, DOI 10.1111-j.1530-0277.1993.tb05645.x; LEE S, 1995, ALCOHOL CLIN EXP RES, V19, P200, DOI 10.1111-j.1530-0277.1995.tb01493.x; MAJUMDAR SK, 1988, DRUG ALCOHOL DEPEN, V21, P231, DOI 10.1016-0376-8716(88)90074-9; Mangold DL, 2000, NEUROPSYCHOPHARMACOL, V22, P595, DOI 10.1016-S0893-133X(99)00149-9; MCDONALD JA, 1993, J GASTROEN HEPATOL, V8, P247, DOI 10.1111-j.1440-1746.1993.tb01195.x; MERRY J, 1972, LANCET, V2, P990; Moselhy HF, 2001, ALCOHOL ALCOHOLISM, V36, P357, DOI 10.1093-alcalc-36.5.357; NOLAN CJ, 1991, LIFE SCI, V49, P1923, DOI 10.1016-0024-3205(91)90294-L; Ogilvie K, 1998, ALCOHOL CLIN EXP RES, V22, p243S, DOI 10.1111-j.1530-0277.1998.tb04010.x; Oswald LM, 2004, PHYSIOL BEHAV, V81, P339, DOI 10.1016-j.physbeh.2004.02.008; Phillips TJ, 1997, PHARMACOL BIOCHEM BE, V57, P487, DOI 10.1016-S0091-3057(96)00448-0; Rasmussen DD, 2000, ALCOHOL CLIN EXP RES, V24, P1836, DOI 10.1111-j.1530-0277.2000.tb01988.x; Redei E, 1990, Prog Clin Biol Res, V325, P313; Rivier C, 1996, ALCOHOL CLIN EXP RES, V20, P240, DOI 10.1111-j.1530-0277.1996.tb01636.x; Rivier Catherine, 1999, Frontiers in Bioscience, V4, pD514, DOI 10.2741-Rivier; Rivier C, 1997, ALCOHOL CLIN EXP RES, V21, P1690, DOI 10.1097-00000374-199712000-00020; RIVIER C, 1993, ALCOHOL CLIN EXP RES, V17, P946, DOI 10.1111-j.1530-0277.1993.tb05646.x; ROBERTS AJ, 1992, BRAIN RES, V579, P296, DOI 10.1016-0006-8993(92)90064-G; ROBERTS AJ, 1991, ALCOHOL CLIN EXP RES, V15, P412, DOI 10.1111-j.1530-0277.1991.tb00539.x; ROY A, 1990, PSYCHIAT RES, V33, P215, DOI 10.1016-0165-1781(90)90038-7; Roy A, 2002, J PHARMACOL EXP THER, V301, P774, DOI 10.1124-jpet.301.2.774; Ryabinin AE, 2002, ALCOHOL CLIN EXP RES, V26, P714; Serra M, 2003, J NEUROCHEM, V85, P257, DOI 10.1046-j.1471-4159.2003.01680.x; Siggins GR, 2003, ANN NY ACAD SCI, V1003, P196, DOI 10.1196-annals.1300.012; Silva SM, 2002, BRAIN RES, V954, P82, DOI 10.1016-S0006-8993(02)03346-2; Soderpalm AHV, 2002, ALCOHOL CLIN EXP RES, V26, P818, DOI 10.1111-j.1530-0277.2002.tb02610.x; SPENCER RL, 1990, NEUROENDOCRINOLOGY, V52, P481, DOI 10.1159-000125632; Spencer RL, 1999, ALCOHOL RES HEALTH, V23, P272; TARGUM SD, 1982, J AFFECT DISORDERS, V4, P347, DOI 10.1016-0165-0327(82)90030-1; THIAGARAJAN AB, 1989, NEUROENDOCRINOLOGY, V50, P427, DOI 10.1159-000125259; Umhau JC, 2001, ALCOHOL CLIN EXP RES, V25, P781, DOI 10.1111-j.1530-0277.2001.tb02279.x; WALTMAN C, 1993, J CLIN ENDOCR METAB, V77, P518, DOI 10.1210-jc.77.2.518; Wand GS, 1999, ALCOHOL CLIN EXP RES, V23, P1185, DOI 10.1097-00000374-199907000-00007; WAND GS, 1991, J CLIN ENDOCR METAB, V72, P1290; Weinberg J, 1996, ALCOHOL CLIN EXP RES, V20, P122, DOI 10.1111-j.1530-0277.1996.tb01054.x; Wilkins J N, 1992, Recent Dev Alcohol, V10, P57 |
dc.description.citedCount | 23 |
dc.description.citedTotWOSCount | 26 |
dc.description.citedWOSCount | 21 |
dc.format.extentCount | 11 |
dc.identifier.articleNo | |
dc.identifier.coden | BBRCA |
dc.identifier.pubmedID | 15369760 |
dc.identifier.scopusID | 4544349406 |
dc.identifier.url | |
dc.publisher.address | 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA |
dc.relation.ispartofConference | |
dc.relation.ispartofConferenceCode | |
dc.relation.ispartofConferenceDate | |
dc.relation.ispartofConferenceHosting | |
dc.relation.ispartofConferenceLoc | |
dc.relation.ispartofConferenceSponsor | |
dc.relation.ispartofConferenceTitle | |
dc.relation.ispartofFundingAgency | |
dc.relation.ispartOfISOAbbr | Biochem. Biophys. Res. Commun. |
dc.relation.ispartOfIssue | 2 |
dc.relation.ispartOfPart | |
dc.relation.ispartofPubTitle | Biochemical and Biophysical Research Communications |
dc.relation.ispartofPubTitleAbbr | Biochem. Biophys. Res. Commun. |
dc.relation.ispartOfSpecialIssue | |
dc.relation.ispartOfSuppl | |
dc.relation.ispartOfVolume | 323 |
dc.source.ID | WOS:000224076900001 |
dc.type.publication | Journal |
dc.subject.otherAuthKeyword | ACTH |
dc.subject.otherAuthKeyword | Alcohol |
dc.subject.otherAuthKeyword | CNS |
dc.subject.otherAuthKeyword | CORT |
dc.subject.otherAuthKeyword | Cytokine |
dc.subject.otherAuthKeyword | HPA |
dc.subject.otherAuthKeyword | Inflammation |
dc.subject.otherAuthKeyword | Neuro-immune-endocrine system |
dc.subject.otherChemCAS | alcohol, 64-17-5 |
dc.subject.otherChemCAS | nitric oxide, 10102-43-9 |
dc.subject.otherChemCAS | Adrenocorticotropic Hormone, 9002-60-2 |
dc.subject.otherChemCAS | Corticosterone, 50-22-6 |
dc.subject.otherChemCAS | Ethanol, 64-17-5 |
dc.subject.otherIndex | alcohol |
dc.subject.otherIndex | hormone |
dc.subject.otherIndex | leptin |
dc.subject.otherIndex | nitric oxide |
dc.subject.otherIndex | steroid |
dc.subject.otherIndex | alcoholism |
dc.subject.otherIndex | behavior |
dc.subject.otherIndex | brain |
dc.subject.otherIndex | endocrine system |
dc.subject.otherIndex | hippocampus |
dc.subject.otherIndex | human |
dc.subject.otherIndex | hypothalamus hypophysis system |
dc.subject.otherIndex | immune system |
dc.subject.otherIndex | immunology |
dc.subject.otherIndex | limbic system |
dc.subject.otherIndex | neurochemistry |
dc.subject.otherIndex | physical chemistry |
dc.subject.otherIndex | priority journal |
dc.subject.otherIndex | regulatory mechanism |
dc.subject.otherIndex | review |
dc.subject.otherIndex | signal transduction |
dc.subject.otherIndex | Adrenocorticotropic Hormone |
dc.subject.otherIndex | Alcoholism |
dc.subject.otherIndex | Animals |
dc.subject.otherIndex | Corticosterone |
dc.subject.otherIndex | Ethanol |
dc.subject.otherIndex | Humans |
dc.subject.otherIndex | Hypothalamo-Hypophyseal System |
dc.subject.otherIndex | Neuroimmunomodulation |
dc.subject.otherIndex | Neurosecretory Systems |
dc.subject.otherIndex | Pituitary-Adrenal System |
dc.subject.otherKeywordPlus | PITUITARY-ADRENAL AXIS |
dc.subject.otherKeywordPlus | CORTICOTROPIN-RELEASING FACTOR |
dc.subject.otherKeywordPlus | DEXAMETHASONE SUPPRESSION TEST |
dc.subject.otherKeywordPlus | BETA-ENDORPHIN |
dc.subject.otherKeywordPlus | ETHANOL WITHDRAWAL |
dc.subject.otherKeywordPlus | FAMILY-HISTORY |
dc.subject.otherKeywordPlus | CORTISOL RESPONSES |
dc.subject.otherKeywordPlus | STIMULATION TEST |
dc.subject.otherKeywordPlus | EXPOSURE ALTERS |
dc.subject.otherKeywordPlus | ACTH-SECRETION |
dc.subject.otherWOS | Biochemistry and Molecular Biology |
dc.subject.otherWOS | Biophysics |
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |